These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7927991)

  • 1. Influence of synthetic adjuvants on nonspecific resistance to infections.
    Parant M
    Int J Immunopharmacol; 1994; 16(5-6):445-9. PubMed ID: 7927991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic value of muramyl peptides for modulating human immunologic responses.
    Fogler WE
    Biotechnol Ther; 1989-1990; 1(1):69-83. PubMed ID: 2562645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators.
    O'Reilly T; Zak O
    Clin Infect Dis; 1992 May; 14(5):1100-9. PubMed ID: 1600012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: inducer of cytokines in vivo: overview of field and romurtide experience.
    Azuma I
    Int J Immunopharmacol; 1992 Apr; 14(3):487-96. PubMed ID: 1618600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunopharmacological activities of bacterial cell walls and related synthetic compounds (muramyl peptides)].
    Kotani S; Takada H
    Yakugaku Zasshi; 1983 Jan; 103(1):1-27. PubMed ID: 6191019
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of non-specific resistance to infection by muroctasin.
    Otani T; Une T; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.
    Parant M; Chedid L
    Infection; 1984; 12(3):230-4. PubMed ID: 6469369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni infections.
    Masihi KN; Bhaduri CR; Werner H; Janitschke K; Lange W
    Int Arch Allergy Appl Immunol; 1986; 81(2):112-7. PubMed ID: 3759255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancers of nonspecific immunity induce nitric oxide synthase: induction does not correlate with toxicity or adjuvancy.
    Palacios M; Knowles RG; Moncada S
    Eur J Immunol; 1992 Sep; 22(9):2303-7. PubMed ID: 1381314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
    Leclerc C; Chedid L
    Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani in hamsters: stimulation of non-specific resistance by some novel glycopeptides and impact on therapeutic efficacy.
    Pal R; Anuradha ; Rizvi SY; Kundu B; Mathur KB; Katiyar JC
    Experientia; 1991 May; 47(5):486-90. PubMed ID: 2044704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
    Ishihara C; Yamamoto K; Hamada N; Azuma I
    Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic immunomodulators and synthetic vaccines.
    Leclerc C; Vogel FR
    Crit Rev Ther Drug Carrier Syst; 1986; 2(4):353-406. PubMed ID: 3103928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of muramyl peptides and tumor necrosis factor on oxidative responses of human blood phagocytes.
    Jupin C; Parant M; Chedid L
    Immunol Lett; 1989 Sep; 22(3):187-92. PubMed ID: 2553589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhancement of host defenses against infection--search for the Holy Grail?
    Polk HC
    Surgery; 1986 Jan; 99(1):1-6. PubMed ID: 3941994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
    Dinarello CA; Elin RJ; Chedid L; Wolff SM
    J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.